Journal article
Host Genomics in Infectious Diseases
Abstract
Understanding mechanisms by which genetic variants predispose to complications of infectious diseases can lead to important benefits including the development of biomarkers to prioritize vaccination or prophylactic therapy. Family studies, candidate genes in animal models, and the absence of well-defined risks where the complications are rare all can point to genetic predisposition. The most common approach to assessing genetic risk is to …
Authors
Loeb M
Journal
Infection and Chemotherapy, Vol. 45, No. 3, pp. 253–259
Publisher
XMLink
Publication Date
2013
DOI
10.3947/ic.2013.45.3.253
ISSN
1598-8112